GetTopicDetailResponse(id=d9cb1216e359, topicName=CD19 CAR-T, introduction=, content=B細胞急性淋巴細胞白血病 CD19 CAR-T, image=null, comments=0, allHits=412, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon Nov 25 17:33:40 CST 2024, time=2024-11-25, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=465983, tagList=[TagDto(tagId=465983, tagName=CD19 CAR-T)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2275966, encodeId=564d22e5966d6, content=<a href='/topic/show?id=247743555b6' target=_blank style='color:#2F92EE;'>#大B細胞淋巴瘤#</a> <a href='/topic/show?id=d9cb1216e359' target=_blank style='color:#2F92EE;'>#CD19 CAR-T#</a>, objectTitle=CD19 CAR-T治療B-NHL和CLL的10年隨訪證實長期生存獲益, objectType=article, longId=889996, objectId=8e608899968e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220813/1660373278819_8252897.webp, objectUrl=/article/show_article.do?id=8e608899968e, replyNumber=0, likeNumber=18, createdTime=2025-08-04, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8e608899968e, moduleTitle=CD19 CAR-T治療B-NHL和CLL的10年隨訪證實長期生存獲益, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8e608899968e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2273552, encodeId=679a22e3552db, content=<a href='/topic/show?id=18f43131be' target=_blank style='color:#2F92EE;'>#B-ALL#</a> <a href='/topic/show?id=d9cb1216e359' target=_blank style='color:#2F92EE;'>#CD19 CAR-T#</a>, objectTitle=【JITC】CD19 CAR-T治療B-ALL失敗后CD22 CAR-T治療有效, objectType=article, longId=886820, objectId=c57488682079, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230622/1687368935777_5579292.jpg, objectUrl=/article/show_article.do?id=c57488682079, replyNumber=0, likeNumber=20, createdTime=2025-07-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c57488682079, moduleTitle=【JITC】CD19 CAR-T治療B-ALL失敗后CD22 CAR-T治療有效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c57488682079)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2268185, encodeId=5809226818540, content=<a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=d9cb1216e359' target=_blank style='color:#2F92EE;'>#CD19 CAR-T#</a>, objectTitle=【JHO】蘇附一院前瞻性研究，CD19 CAR-T治療復發(fā)性t(8;21) AML, objectType=article, longId=880681, objectId=87af880681b8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230616/1686931044843_5579292.jpg, objectUrl=/article/show_article.do?id=87af880681b8, replyNumber=0, likeNumber=0, createdTime=2025-06-06, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=87af880681b8, moduleTitle=【JHO】蘇附一院前瞻性研究，CD19 CAR-T治療復發(fā)性t(8;21) AML, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=87af880681b8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2248641, encodeId=9264224864106, content=<a href='/topic/show?id=921a385567' target=_blank style='color:#2F92EE;'>#B細胞非霍奇金淋巴瘤#</a> <a href='/topic/show?id=d9cb1216e359' target=_blank style='color:#2F92EE;'>#CD19 CAR-T#</a>, objectTitle=CD19 CAR-T治療R/R B細胞淋巴瘤后的免疫重建具有預后意義, objectType=article, longId=859983, objectId=590d8599832b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240509/1715223995977_5579292.jpg, objectUrl=/article/show_article.do?id=590d8599832b, replyNumber=0, likeNumber=0, createdTime=2025-01-18, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=590d8599832b, moduleTitle=CD19 CAR-T治療R/R B細胞淋巴瘤后的免疫重建具有預后意義, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=590d8599832b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2239109, encodeId=2580223910900, content=<a href='/topic/show?id=ef26384487' target=_blank style='color:#2F92EE;'>#B細胞急性淋巴細胞白血病#</a> <a href='/topic/show?id=d9cb1216e359' target=_blank style='color:#2F92EE;'>#CD19 CAR-T#</a>, objectTitle=異基因CD34+造血干細胞boost治療ALL CART后長期血細胞減少的11例報道, objectType=article, longId=852205, objectId=8c4785220573, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220801/1659324313353_8252897.webp, objectUrl=/article/show_article.do?id=8c4785220573, replyNumber=0, likeNumber=0, createdTime=2024-11-25, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=8c4785220573, moduleTitle=異基因CD34+造血干細胞boost治療ALL CART后長期血細胞減少的11例報道, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8c4785220573)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-11-25發(fā)表于陜西省
